Evolving role of endovascular treatment of acute ischemic stroke

Current Neurology and Neuroscience Reports

Volumn 14, Issue 1, 2014, Pages

  Ciccone, Alfonso ^a   Del Zoppo, Gregory J ^b  

^a CARLO POMA HOSPITAL   (Italy)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Catheter based treatment; Cerebral infarction; Cerebrovascular accident; Embolectomy; Fibrinolysis; Interventional radiology; Intra arterial rt PA; Intra arterial thrombolysis; Intravenous rt PA; Mechanical thrombolysis; Stroke; Systemic thrombolysis

Indexed keywords

ALTEPLASE; HEPARIN; NASARUPLASE BETA; PLACEBO; PLASMIN; SARUPLASE; STREPTOKINASE; UROKINASE; TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; BRAIN ISCHEMIA; CAROTID ARTERY THROMBOSIS; CEREBRAL REVASCULARIZATION; DRUG EFFICACY; ENDOVASCULAR SURGERY; FIBRINOLYTIC THERAPY; HUMAN; MIDDLE CEREBRAL ARTERY OCCLUSION; OCCLUSIVE CEREBROVASCULAR DISEASE; STENT RETRIEVER; THERAPY EFFECT; THROMBECTOMY DEVICE; THROMBUS ASPIRATION; CEREBROVASCULAR ACCIDENT; METHODOLOGY; REVIEW;

ENDOVASCULAR PROCEDURES; HUMANS; STROKE; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84887756531     PISSN: 15284042     EISSN: 15346293     Source Type: Journal    
DOI: 10.1007/s11910-013-0416-6     Document Type: Article

References (47)

1. Wardlaw JM, Murray V, Berge E, et al. Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis. Lancet. 2012;379:2364- 72.
2. Broderick JP, Palesch YY, Demchuk AM, et al. Endovascular therapy after intravenous rt-PA versus rt-PA alone for stroke. N Engl J Med. 2013;368:893-903.
3. Ciccone A, Valvassori L, Nichelatti M, et al. Endovascular treatment for acute ischemic stroke. N Engl J Med. 2013;368:904-13.
4. Kidwell CS, Jahan R, Gornbein J, et al. A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med. 2013;368:914-23.
5. del Zoppo GJ, Zeumer H, Harker LA. Thrombolytic therapy in acute stroke: Possibilities and hazards. Stroke. 1986;17:595-607.
6. Fletcher AP, Alkjaersig N, Lewis M, et al. A pilot study of urokinase therapy in cerebral infarction. Stroke. 1976;7:135-42.
7. Hanaway J, Torack R, Fletcher AP, et al. Intracranial bleeding associated with urokinase therapy for acute ischemic hemispheral stroke. Stroke. 1976;7:143-6.
8. Caplan L. "Top of the basilar" syndrome: selected clinical aspects. Neurology. 1980;30:72-9.
9. Archer CT, Horenstein S. Basilar artery occlusion. Clinical and radiological correlation. Stroke. 1977;8:383-7.
10. Nenci GG, Gresele P, Taramelli M, et al. Thrombolytic therapy for thromboembolism of vertebrobasilar artery. Angiology. 1983;34: 561-71.
11. Hacke W, Zeumer H, Ferbert A, et al. Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease. Stroke. 1988;19:1216-22.
12. del Zoppo GJ, Ferbert A, Otis S, et al. Local intra-arterial fibrinolytic therapy in acute carotid territory stroke: a pilot study. Stroke. 1988;19:307-13.
13. Mori E, Tabuchi M, Yoshida T, et al. Intracarotid urokinase with thromboembolic occlusion of the middle cerebral artery. Stroke. 1988;19:802-12.
14. Zeumer H, Freitag HJ, Grzyka U, et al. Local intra-arterial fibrinolysis in acute vertebrobasilar occlusion. Technical developments and recent results. Neuroradiology. 1989;31: 336-40.
15. Krause KH, Jackenkroll R, Betz H, et al. Recanalization of the internal carotid artery in a case of prolonged reversible ischemic neurological deficit. Nervenarzt. 1981;52:197-201.
16. del Zoppo GJ, Higashida RT, Furlan AJ, et al. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke. 1998;29:4-11.
17. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA. 1999;282:2003-11.
18. Ogawa A, Mori E, Minematsu K, et al. Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke. The Middle Cerebral Artery Embolism Local Fibrinolygic Intervention Trial (MELT) Japan. Stroke. 2007;38:2633-9.
19. Macleod MR, Davis SM, Mitchell JP, et al. Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovascular Dis. 2005;20:12-7.
20. Nogueira RG, Schwamm LH, Hirsch JA. Endovascular approaches to acute stroke, Part 1: Drugs, devices, and data. Am J Neurorad. 2009;30:649-61.
21. Smith WS, Sung G, Starkman S, et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke. 2005;36:1432-8.
22. Smith WS, Sung G, Saver J, et al. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke. 2008;39:1205-12.
23. Penumbra Pivotal Stroke Trial Investigators. The Penumbra Pivotal Stroke Trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke. 2009;40:2761-8.
24. Nogueira RG, Lutsep HL, Gupta R, et al. Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet. 2012;380:1231-40.
25. Saver JL, Jahan R, Levy EI, et al. Solitaire flow restoration device versus the Merci retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet. 2012;380:1241-9.
26. Mikulik R, Dusek L, Hill MD, et al. Pattern of response of National Institutes of Health Stroke Scale components to early recanalization in the CLOTBUST trial. Stroke. 2010;41:466-70.
27. Balucani C, Alexandrov AV. Ultrasound- and microspheresenhanced thrombolysis for stroke treatment: state of the art. Curr Cardiol Rep. 2010;12:34-41.
28. Mullen MT, Pisapia JM, Tilwa S, et al. Systematic review of outcome after ischemic stroke due to anterior circulation occlusion treated with intravenous, intra-arterial, or combined intravenous+ intra-arterial thrombolysis. Stroke. 2012;43:2350-5.
29. Kaptchuk TJ. Powerful placebo: the dark side of the randomised controlled trial. Lancet. 1998;351:1722-5.
30. Bailar 3rd JC. The powerful placebo and theWizard of Oz. N Engl J Med. 2001;344:1630-2.
31. Hussein HM, Georgiadis AL, Vazquez G, et al. Occurrence and predictors of futile recanalization following endovascular treatment among patients with acute ischemic stroke: a multicenter study. AJNR Am J Neuroradiol. 2010;31:454-8.
32. Sorimachi T, Fujii Y, Tsuchiya N, et al. Recanalization bymechanical embolus disruption during intra-arterial thrombolysis in the carotid territory. AJNR Am J Neuroradiol. 2004;25:1391-402.
33. Ringer AJ, Qureshi AI, Fessler RD, et al. Angioplasty of intracranial occlusion resistant to thrombolysis in acute ischemic stroke. Neurosurgery. 2001;48:1282-8.
34. Qureshi AI, Siddiqui AM, Suri MF, et al. Aggressive mechanical clot disruption and low-dose intra-arterial third-generation thrombolytic agent for ischemic stroke: a prospective study. Neurosurgery. 2002;51:1319-27.
35. Bergui M, Stura G, Daniele D, et al. Mechanical thrombolysis in ischemic stroke attributable to basilar artery occlusion as first-line treatment. Stroke. 2006;37:145-50.
36. Leys D, Ringelstein EB, Kaste M, Hacke W. The main components of stroke unit care: Results of a European expert survey. Cerebrovasc Dis. 2007;23:344-52.
37. Consoli D, de Falco FA, Lenzi GL, Miceli G, Palombo F, Rosati G, Simonetti G, Stanzione P, Ugenti R, Zangrillo A. Cap 4. Le Stroke Unit: definizioni, criteri di accreditamento, indicatori e verifiche di qualità. Pp 13-19. In: Organizzazione dell'assistenza all'ictus: le Stroke Unit. Ministero della Salute Editor. Quaderni del Ministero della Salute, n.2, marzo-aprile 2010. Available at: http://www.quadernidellasalute.it/ archivio-quaderni/2-marzo-aprile-2010.php. Accessed 20 Oct 2013.
38. Ciccone A, Valvassori L, Gasparotti R, et al. Debunking 7 myths that hamper the realization of randomized controlled trials on intra-arterial thrombolysis for acute ischemic stroke. Stroke. 2007;38:2191-5.
39. Johnston SC, Hauser SL. The dangers of clinical conviction: an "M&M" of endovascular therapies for stroke. Ann Neurol. 2013;73:A5-6.
40. Goyal M, Swartz RH. Epistemology, parachutes, and "yeah, but" interventional stroke trials. Stroke. 2013;44:2036-8.
41. Hacke W, Donnan G, Fieschi C, et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet. 2004;363:768-74.
42. Easton JD, Saver JL, Albers GW, et al. Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists. Stroke. 2009;40:2276-93.
43. Nogueira RG, SmithWS, Sung G, et al. Effect of time to reperfusion on clinical outcome of anterior circulation strokes treated with thrombectomy: pooled analysis of the MERCI and Multi MERCI trials. Stroke. 2011;42:3144-9.
44. Liebeskind DS, Sanossian N, Yong WH, et al. CT and MRI early vessel signs reflect clot composition in acute stroke. Stroke. 2011;42: 1237-43.
45. Legrand L, Naggara O, Turc G, et al. Clot burden score on admission T2*-MRI predicts recanalization in acute stroke. Stroke. 2013;44: 1878-84.
46. Bang OY, Saver JL, Kim SJ, et al. Collateral flow predicts response to endovascular therapy for acute ischemic stroke. Stroke. 2011;42:693-9.
47. McVerry F, Liebeskind DS,Muir KW. Systematic review of methods for assessing leptomeningeal collateral flow. AJNR Am J Neuroradiol. 2012;33:576-82.